Publication:
An Open-Label Trial to Assess the Safety of Regorafenib in Turkish Patients with Metastatic Colorectal Cancer (mCRC) That Progressed on Standard Therapy (REGARD)

Research Projects

Organizational Units

Journal Issue

Abstract

Description

ESMO 17th World Congress on Gastrointestinal Cancer -- JUL 01-04, 2015 -- Barcelona, SPAIN

Keywords

Citation

WoS Q

Scopus Q

Source

Volume

26

Issue

Start Page

End Page

Endorsement

Review

Supplemented By

Referenced By